{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gout/supporting-evidence/dietary-measures/","result":{"pageContext":{"chapter":{"id":"409d2bc0-16d2-5104-8857-eeb5db2a1ecc","slug":"dietary-measures","fullItemName":"Dietary measures","depth":2,"htmlHeader":"<!-- begin field a27dc656-1432-46fd-bfce-4c2ac5146864 --><h2>Evidence supporting dietary measures to prevent recurrent attacks of gout</h2><!-- end field a27dc656-1432-46fd-bfce-4c2ac5146864 -->","summary":null,"htmlStringContent":"<!-- begin item 4d93e955-46cd-4f9d-b9d4-3094f9f7f0f6 --><!-- end item 4d93e955-46cd-4f9d-b9d4-3094f9f7f0f6 -->","topic":{"id":"7ec7842e-cb8a-5712-bb55-65480a391cb5","topicId":"b578fac4-ab4b-4d7b-9df9-2136b4d90e75","topicName":"Gout","slug":"gout","lastRevised":"Last revised in February 2018","chapters":[{"id":"2e71494e-f9a3-5368-8903-3d2121329748","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"738bb44e-1a50-5bc5-8df4-83ac66475493","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"69338c48-0d43-5ae0-9591-5ef289880366","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0f7680ff-9a88-520a-b2b5-1ff130dfa69b","slug":"changes","fullItemName":"Changes"},{"id":"ae66c6f1-78f9-5532-b310-9d6957882c0c","slug":"update","fullItemName":"Update"}]},{"id":"5de6e4cf-e0c8-56e2-a357-3d063b324cd0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"86664a1d-e3e5-58c9-957b-56affa17f103","slug":"goals","fullItemName":"Goals"},{"id":"39593d8e-f904-5b99-80e9-e619caf1ec37","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ca59f248-a0b2-5f6c-bfcf-2333dc94f1d9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"57ca55f4-826e-5832-85a7-dd89f3486be2","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"621c09b7-b5e8-593b-aeb2-fc4a86b884c8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b39fbed2-7c0d-5440-a769-bab311a7b4d2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"362edeaf-2f90-506d-b203-f5dbbbfb5835","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a8de4056-6ec0-59ff-911b-561bf7fdb32d","slug":"definition","fullItemName":"Definition"},{"id":"45a8241d-2a2d-5a48-a6d6-2b5ebe02ec27","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"92d229bf-8656-5cfa-aecc-9c069389300f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"79d3b1c2-8d49-55be-99af-41b37c84d582","slug":"complications","fullItemName":"Complications"},{"id":"27dd91cd-92bb-5c2d-8fe8-a184bffce6e7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"ca0e383b-327b-58c2-adb4-6c5081b6fd8e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ddea0193-0c14-53db-8e1e-2e71f514988e","slug":"assessment","fullItemName":"Assessment"},{"id":"5a86623b-b32c-5e12-b9fe-b1b5a1f7e58f","slug":"investigations","fullItemName":"Investigations"},{"id":"42a5d4a2-b908-5027-8fb8-f5f336db4c7e","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5a915955-8e0e-54ae-a1cc-f5875d84d2a2","fullItemName":"Management","slug":"management","subChapters":[{"id":"8a8b4d2a-4efb-5bef-9780-70dc540d41bd","slug":"acute-gout","fullItemName":"Scenario: Acute gout"},{"id":"98793041-11dd-5159-a376-82f5440ee713","slug":"preventing-gout","fullItemName":"Scenario: Preventing gout"}]},{"id":"050e571e-a7a5-5659-9790-2daf0b56580a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e7cfef3f-4ab1-5d17-8300-30e91a70eb96","slug":"nsaids","fullItemName":"NSAIDs"},{"id":"cadf7df3-5301-560b-a8ff-e85cfee9ba7c","slug":"colchicine","fullItemName":"Colchicine"},{"id":"60f4beab-f8fc-50e5-8ed9-5073dd8533ec","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"2d2fee49-9ad0-5f0a-9ef1-f253794ed2c7","slug":"allopurinol","fullItemName":"Allopurinol"},{"id":"9830ccbd-f551-5585-a69a-4674759f70cd","slug":"febuxostat","fullItemName":"Febuxostat"},{"id":"ff3edf82-1b21-591c-a8a5-a3b40e7386a5","slug":"paracetamol","fullItemName":"Paracetamol"}]},{"id":"776d98f0-f8da-57c2-983e-1291ac67b761","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[{"id":"71a86333-9110-5847-a2c2-eabf7903c269","slug":"application-of-an-ice-pack","fullItemName":"Application of an ice pack"},{"id":"25688946-80c0-52ab-a32d-99ccab4d738c","slug":"nsaids","fullItemName":"NSAIDs"},{"id":"2921e0f0-467f-5231-87d0-9fed766653ee","slug":"oral-colchicine","fullItemName":"Oral colchicine"},{"id":"09bbf9d4-fe62-5ae1-bc49-f2fede12f711","slug":"corticosteroids","fullItemName":"Corticosteroids"},{"id":"409d2bc0-16d2-5104-8857-eeb5db2a1ecc","slug":"dietary-measures","fullItemName":"Dietary measures"},{"id":"08526f72-ca5a-50db-94b6-3380365360fd","slug":"colchicine-to-prevent-recurrent-gout","fullItemName":"Colchicine to prevent recurrent gout"},{"id":"a53517a7-6d7e-5d2f-886d-e2a3f1bc27b1","slug":"urate-lowering-drugs-in-prevention","fullItemName":"Urate-lowering drugs in prevention"}]},{"id":"f83d98a9-6ce1-50d4-92ad-dd354662a444","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"568c43a6-b0d8-546e-84d2-45781ce305cc","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"5b7cac11-c21d-59fc-83d9-bf16d0d3ab0b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0e4d0013-b7bc-5179-ac55-8104dec2762c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d75afbe0-7c3d-504e-b369-e56eac297bad","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"45249d1d-8c92-5402-b4f3-108a8a39d94f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"44f1a411-2cf4-55e8-b5e8-266cd568655e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"776d98f0-f8da-57c2-983e-1291ac67b761","slug":"supporting-evidence","fullItemName":"Supporting evidence"},"subChapters":[{"id":"2d868bde-259d-5990-b886-6f6456837cf9","slug":"moderating-alcohol-intake","fullItemName":"Moderating alcohol intake","depth":3,"htmlHeader":"<!-- begin field eeb78c59-f169-4365-9970-fb8ecd4e624b --><h3>Moderating alcohol intake</h3><!-- end field eeb78c59-f169-4365-9970-fb8ecd4e624b -->","summary":null,"htmlStringContent":"<!-- begin item b42e18be-a864-41ab-8a0d-083f6b7fe90a --><!-- begin field b337c817-0e44-452c-8c8b-1186a0504042 --><ul><li>CKS could find no studies that specifically looked at the effect of alcohol reduction on recurrence rates in people with gout.</li><li>A study that followed 47,150 men over a period of 12 years found that alcohol intake was strongly associated with an increased relative risk of gout. The risk varied according to quantity and type of alcoholic beverage: beer conferred a larger risk than spirits. Moderate wine drinking did not increase the risk of gout [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2004b</a>]. Two subsequent review articles reported similar findings [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>].</li><li>A population survey found alcohol consumption to be predictive of gout in hyperuricaemic people irrespective of the level of plasma uric acid (OR 2.31, 95% CI 1.04 to 5.54) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Lin et al, 2000a</a>].</li><li>A prospective observational study of 233 men with raised plasma uric acid found that alcohol consumption was an independent predictor of the onset of gout (OR 3.45, 95% CI 1.58 to 7.56) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Lin et al, 2000b</a>].</li></ul><!-- end field b337c817-0e44-452c-8c8b-1186a0504042 --><!-- end item b42e18be-a864-41ab-8a0d-083f6b7fe90a -->","subChapters":[]},{"id":"9f6ea0a0-b2cf-54e4-97e6-cf39038be126","slug":"dietary-changes","fullItemName":"Dietary changes","depth":3,"htmlHeader":"<!-- begin field ae265fb9-166b-42ce-820e-9ee3afd500ee --><h3>Dietary changes</h3><!-- end field ae265fb9-166b-42ce-820e-9ee3afd500ee -->","summary":null,"htmlStringContent":"<!-- begin item 961856ef-bbfc-4e52-88f4-5e500362a805 --><!-- begin field 62e8928c-5628-49e3-8a3d-d050676eb4d8 --><ul><li>A study that followed 47,150 men over a period of 12 years found increased relative risks (RR) for gout associated with high levels of consumption of meat and seafood respectively (RR 1.41, 95% CI 1.07 to 1.86; RR 1.51, 95% CI 1.17 to 1.95) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2004a</a>].<ul><li>The study found no evidence for increased risk of gout from eating vegetables with high purine content (peas, beans, lentils, spinach, mushrooms, oatmeal, and cauliflower), and concluded that moderate intakes of purine-rich vegetables or protein are not associated with an increased risk of gout.</li><li>The study also showed that high levels of consumption of dairy products were associated with a decreased risk of gout [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2004a</a>]. A subsequent review article reported similar findings [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>].</li></ul></li><li>There is also some evidence (mostly from observational studies) that high level of consumption of low fat dairy products [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Dalbeth and Palmano, 2011</a>], limiting sugary drinks and snacks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi and Curhan, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>], and taking vitamin C supplements (500 mg/day or more) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>] may reduce the risk of gout. Although good quality randomized controlled trials are needed to support or refute this, these recommendations are safe and have multiple health benefits [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>].<ul><li>Low-fat dairy foods have been linked to a lower incidence of cardiovascular heart disease, premenopausal breast cancer, colon cancer, type 2 diabetes, and hypertension.</li><li>High intake of sugary foods and drinks has been linked to weight gain, obesity, type 2 diabetes, an increased risk of certain cancers, and symptomatic gallstone disease.</li><li>Vitamin C is safe, particularly within the recommended ranges (< 2000 mg/day in adults), and has cardioprotective properties.<!--_c2a0_2000c2a0_mg--></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi, 2010</a>]</p><ul><li>A case series of 15 people with gout found that a strict purine-free diet can reduce plasma uric acid by 15–20%, but there was no effect on clinical outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Nicholls and Scott, 1972</a>] (cited in [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Schlesinger and Schumacher, 2004</a>]).</li></ul><!-- end field 62e8928c-5628-49e3-8a3d-d050676eb4d8 --><!-- end item 961856ef-bbfc-4e52-88f4-5e500362a805 -->","subChapters":[]},{"id":"b04d2316-5a53-50f6-aba5-c82b29b07ffc","slug":"avoiding-weight-gain-losing-weight","fullItemName":"Avoiding weight gain, losing weight","depth":3,"htmlHeader":"<!-- begin field df95807f-fba6-4df5-a610-e97da9ea8ccd --><h3>Avoiding weight gain, losing weight</h3><!-- end field df95807f-fba6-4df5-a610-e97da9ea8ccd -->","summary":null,"htmlStringContent":"<!-- begin item b3b3f368-40f4-4977-be2b-69ee817b26b7 --><!-- begin field e43749b6-8a84-44de-adcc-6360bbe8adde --><ul><li>A prospective cohort study followed 47,150 men over a period of 12 years and confirmed 730 cases of gout [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Choi et al, 2005</a>]. The authors concluded that higher adiposity and weight gain are strong risk factors for gout in men, while weight loss is protective.</li><li>Table 2 and Table 3 outline the multivariate relative risks of gout associated with adiposity and weight gain respectively.</li></ul><p><strong>Table 2</strong><strong>. </strong>Multivariate relative risks of gout associated with adiposity.</p><table data-table-id=\"a78d196f-5c82-44be-812f-acce014f3c5f\"><thead><tr><th colspan=\"1\"><p>Body Mass Index (BMI)</p></th><th colspan=\"1\"><p>Relative Risk</p></th><th colspan=\"1\"><p>95% Confidence Interval</p></th></tr></thead><tbody><tr><td colspan=\"1\">21 to 24.9</td><td colspan=\"1\">1</td><td colspan=\"1\">—</td></tr><tr><td colspan=\"1\">25 to 29.9</td><td colspan=\"1\">1.95</td><td colspan=\"1\">1.44–2.65</td></tr><tr><td colspan=\"1\">30 to 34.9</td><td colspan=\"1\">2.33</td><td colspan=\"1\">1.62–3.36</td></tr><tr><td colspan=\"1\">35 or greater</td><td colspan=\"1\">2.97</td><td colspan=\"1\">1.73–5.10</td></tr><tr><td colspan=\"3\"><strong>p< 0.001 for trend</strong></td></tr></tbody></table><p><strong>Table 3</strong><strong>. </strong>Multivariate relative risks of gout associated with weight gain.</p><table data-table-id=\"7b39b4be-92d9-4bee-8632-acce014f3c5f\"><thead><tr><th colspan=\"1\"><p>Change in weight</p></th><th colspan=\"1\"><p>Relative Risk</p></th><th colspan=\"1\"><p>95% Confidence Interval</p></th></tr></thead><tbody><tr><td colspan=\"1\">Lost 10 lb or more since study baseline</td><td colspan=\"1\">0.61</td><td colspan=\"1\">0.40–0.92</td></tr><tr><td colspan=\"1\">Stable within 4 lb since 21 years old</td><td colspan=\"1\">1</td><td colspan=\"1\">—</td></tr><tr><td colspan=\"1\">Gained 30 lb or more since 21 years old</td><td colspan=\"1\">1.99</td><td colspan=\"1\">1.49–2.66</td></tr></tbody></table><ul><li>A population survey found central obesity to be predictive of gout in hyperuricaemic people irrespective of the level of plasma uric acid (OR 2.43, 95% CI 1.14 to 5.29) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Lin et al, 2000a</a>].</li><li>A prospective observational study of 233 men with raised plasma uric acid found that excessive weight gain was an independent predictor of the onset of gout (OR 1.91, 95% CI 0.98 to 4.01) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Lin et al, 2000b</a>].</li><li>An observational study of a diet with restricted energy content that was high in complex carbohydrates and mono- and poly-unsaturated fats, included 13 non-diabetic obese men with gout. At 16 weeks the mean frequency of gouty attacks reduced from 2.1 to 0.6 per month. The mean uric acid level decreased from 570 micromol/L to 470 micromol/L [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gout/references/\">Dessein et al, 2000</a>].</li></ul><!-- end field e43749b6-8a84-44de-adcc-6360bbe8adde --><!-- end item b3b3f368-40f4-4977-be2b-69ee817b26b7 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}